Michael St. Andre is currently a Principal Scientist at Entrada Therapeutics, specializing in pharmacology and preclinical drug development. They previously held roles as a Senior Scientist and Scientist at Pfizer from 2019 to 2021. Michael earned a Doctor of Philosophy in Biomolecular Pharmacology from Boston University School of Medicine, completing their degree in 2021.
Location
Boston, United States
This person is not in any offices